In an earnings call covering its 2024 full-year results, executives from Ekso Bionics (Nasdaq: EKSO) described the company’s plans to get its Ekso Indego Personal exoskeleton into the hands of more patients. “Revenue of $17.9 million was down from $18.3 million for the same period in 2023,” Ekso Bionics CFO Jerome Wong said, in describing…
Ekso Bionics to Focus on Indego Personal Exoskeleton Expansion Through CRT, DME Channels
NSM Signs Exclusive Partnership to Distribute Indego Exoskeleton in CRT Market
The Centers for Medicare & Medicaid Services has classified some exoskeletons as braces.
National Seating & Mobility (NSM) has become the exclusive distributor of the Ekso Indego Personal exoskeleton in the Complex Rehab Technology (CRT) industry. In a Feb. 10 news announcement, NSM said the new partnership with Ekso Bionics Holdings Inc. (Nasdaq: EKSO), headquartered in San Rafael, California, will “broaden access to the Ekso Indego-powered exoskeleton device…